US · USD
KYMR
Kymera Therapeutics Inc
- Day's range
- $101.75 – $111.04
- Day's volume
- $101.4M
- 52-week range
- $55.80 – $127.31
Follow KYMR in the Fuolio
See how KYMR weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountKYMR in numbers
- Market cap
- $8.8B
- P/E
- 27.27
- P/B
- 5.84
- Dividend yield (12m)
- 0.00%
KYMR trades at 27.27 times its earnings of the last 12 months.
KYMR price history
KYMR risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +56.13% | +410.50% | +90.89% |
| Volatility (annualized) | 55.02% | 66.24% | 82.74% |
| Largest drawdown | -11.25% | -43.40% | -81.62% |
| Positive months | 5/12 | 17/36 | 26/60 |
How much did investing in KYMR return?
$1,000.00 invested on 11/01/2021 would be worth $1,908.86 today.
- Value today in KYMR
- $1,908.86
- Return over the period
- +90.89%
- Return per year
- +14.02%
- In the S&P 500
- $1,712.05
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
KYMR fundamentals
Valuation
- P/E27.27
- P/B5.84
- EV/EBITDA-25.77
- EV/EBIT-25.17
- EV/Revenue83.93
- P/EBIT-25.17
- P/S83.93
- P/OCF-37.22
- P/FCF-37.03
- Earnings yield-3.97%
- PEG ratio—
- Earnings per share$3.89
- Book value per share$18.15
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio10.34
- Quick ratio—
- Cash ratio1.75
Efficiency
- Gross margin0.00%
- EBITDA margin-325.67%
- Operating margin-333.51%
- Net margin307.72%
- Asset turnover0.06
Profitability
- ROE21.41%
- ROA19.64%
- ROIC-15.31%
- Payout0.00%
Growth
- Revenue CAGR (5 years)10.22%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is KYMR's fair price?
Two classic value formulas, with today's numbers. The current price is $105.98.
- Graham's fair price
- $39.84
- 62.41% below the price
√(22.50 × $3.89 × $18.15)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to KYMR: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
KYMR's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| P/E | 20.40 | 11.67 | 10.59 | 8.90 | 32.76 | -60.94 | — |
| P/B | 4.02 | 3.13 | 3.94 | 2.81 | 7.14 | 9.79 | — |
| Earnings per share | $3.81 | $3.45 | $2.40 | $2.81 | $1.94 | -$1.02 | — |
| Book value per share | $19.35 | $12.87 | $6.46 | $8.88 | $8.89 | $6.34 | — |
| ROE | 19.71% | 26.79% | 37.21% | 31.58% | 21.80% | -16.06% | 55.43% |
| ROIC | -22.12% | -20.66% | -27.66% | -21.71% | -14.44% | -10.77% | — |
| Gross margin | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
| EBITDA margin | -869.87% | -540.16% | -206.08% | -338.02% | -134.74% | -130.87% | -1,410.36% |
| Net margin | 794.04% | 475.57% | 186.99% | 330.60% | 137.60% | -133.96% | -1,405.79% |
KYMR's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $39.2M | $47.1M | $78.6M | $46.8M | $72.8M | $34M |
| Cost of revenue | -$39.2M | -$47.1M | -$78.6M | -$46.8M | — | — |
| Gross profit | $0 | $0 | $0 | $0 | — | — |
| EBITDA | -$341.1M | -$254.3M | -$162M | -$158.3M | -$98.1M | -$44.5M |
| EBIT | -$349.4M | -$261.6M | -$165.5M | -$161.3M | -$100.5M | -$46.3M |
| Financial result | — | — | — | — | — | — |
| Income before tax | -$311.4M | — | — | — | — | — |
| Income tax | -$0 | — | — | -$0 | -$0 | -$0 |
| Net income | $311.4M | $223.9M | $147M | $154.8M | $100.2M | -$45.6M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does KYMR pay dividends?
KYMR has no distributions on record.
About Kymera Therapeutics
- Sector
- Manufacturing
Questions about KYMR
How much is KYMR today?
KYMR is at $105.98 (-3.52% on the day), last traded on 10/06/2026.
What are the P/E and P/B of KYMR?
KYMR trades at a P/E of 27.27 and a P/B of 5.84.
How much did KYMR return in 12 months?
KYMR returned 56.13% in 12 months, with annualized volatility of 55.02% and a largest drawdown of -11.25%.